Society for Translational Oncology


Highlights from STO's educational activities, including content associated with the Society and its journal The Oncologist. RSS Feed URL

Play Latest Episode:

Title: IDH Inhibition in Acute Myeloid Leukemia – Emergence of a New Therapeutic Era

RET As a Target in Lung Cancer

February 19th, 2020

Rearranged during transfection (RET) proto-oncogene rearrangements have been validated as an additional oncogenic driver that occurs in 1-2% of NSCLC.… Go to Episode

Targeting SWI/SNF-Hippo Axis in Squamous Cancers

February 19th, 2020

Squamous cell carcinoma (SCC) remains among the most treatment-refractory of human cancers, reflecting in part a limited understanding of the key pathways… Go to Episode

Innovations in Cell Therapy

February 19th, 2020

Autologous T cells that have been genetically redirected with chimeric antigen receptors (CARs) specific to the CD19 antigen have achieved remarkable… Go to Episode

Beyond PARP1: Ribosylation as a Target for Cancer Therapy

February 5th, 2019

Victoria Richon, PhD Ribon Therapeutics Video Overview: SlidesMuch of the attention on the PARP… Go to Episode